# Insight Lifetech

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/insight-lifetech

- Industry: Medical Devices & Equipment
- Headquarters: Shenzhen, China
- Website: www.insight-med.com/
- Total disclosed funding: $28M
- Latest round: Series D (Sep 19, 2022)
- Investors on record: 14

## About

Headquartered in Shenzhen, China and established in 2015, Insight Lifetech Co., Ltd. provides cardiac interventional diagnostics and treatment solutions for the healthcare industry. The company has developed a platform for the precision care of cardiovascular diseases such as coronary artery disease and atrial fibrillation. The firm holds ISO13485:2016 and ISO14001:2015 certifications and was recognized as a National High-tech Enterprise in 2018. In February 2026, the company was listed on the Shanghai Stock Exchange under the ticker 688712, raising CNY 998.64 million.

The company works with hospitals and clinical professionals to provide precision cardiovascular diagnostics and interventional equipment. Its offerings include the TRUEPHYSIO pressure microcatheter, VivoCardio flow reserve measurement systems, and the TrueCross and TrueReach series of microcatheters for complex interventional procedures.

The company’s revenue is generated by the sale of its proprietary interventional cardiovascular diagnostic systems and microcatheter portfolios to medical institutions.

The company plans to use the proceeds from the IPO to build an industrialization base and expand its research and development for interventional medical devices. It also aims to enhance its market position in precision interventional diagnosis and pursue global commercialization through international talent recruitment and strategic collaborations.

## Funding rounds

- Series D, Sep 19, 2022 — Triwise Capital, HSG, Sherpa Healthcare Partners, TigerYeah Capital, Tppoly Capital, National Innovation Center for High Performance Medical Devices
- Series D, Jun 1, 2021 — Boyu Capital
- Series C, Dec 31, 2020 — Qiming Venture Partners, HSG, SDIC Unity Capital, TigerYeah Capital
- Series B, Apr 7, 2020, $28M — Green Pine Capital Partners, Lotus Lake Capital, Efung Capital, SDIC Unity Capital
- Series B, Nov 14, 2018 — HSG, Sherpa Healthcare Partners
- Series A, Jun 21, 2017 — Decheng Capital
- Angel, May 4, 2016 — TigerYeah Capital, Sibionics
- Angel, Dec 10, 2015 — HSG, Sherpa Healthcare Partners

## Investors

- HSG (https://capitalatlas.ai/funds/hsg) — Angel, Series B, Series C, Series D
- Sherpa Healthcare Partners (https://capitalatlas.ai/funds/sherpa-healthcare-partners) — Angel, Series B, Series D
- TigerYeah Capital (https://capitalatlas.ai/funds/tigeryeah-capital) — Angel, Series C, Series D
- Sibionics — Angel
- Decheng Capital (https://capitalatlas.ai/funds/decheng-capital) — Series A
- Green Pine Capital Partners (https://capitalatlas.ai/funds/green-pine-capital-partners) — Series B
- Lotus Lake Capital (https://capitalatlas.ai/funds/lotus-lake-capital) — Series B
- Efung Capital (https://capitalatlas.ai/funds/efung-capital) — Series B
- SDIC Unity Capital (https://capitalatlas.ai/funds/sdic-unity-capital) — Series B, Series C
- Qiming Venture Partners (https://capitalatlas.ai/funds/qiming-venture-partners) — Series C
- Boyu Capital (https://capitalatlas.ai/funds/boyu-capital) — Series D
- Triwise Capital (https://capitalatlas.ai/funds/triwise-capital) — Series D
- Tppoly Capital (https://capitalatlas.ai/funds/tppoly-capital) — Series D
- National Innovation Center for High Performance Medical Devices — Series D